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Background: The role of multiorgan damage in the mortality caused by ischemic limb injury is still not clarified.
The objective of this study was to examine the potential protective effects of hyperbaric oxygen (HBO) and iloprost
(IL) therapy on lung damage induced by limb ischemia/reperfusion injury in a rabbit model, using both
biochemical and histopathological aspects.
Methods: Forty New Zealand white rabbits were randomly allocated into one of five study groups: HBO group
(single session of HBO treatment); IL group (25 ng/kg/min infusion of IL); HBO+ IL group (both HBO and IL); Control
group (0.9% saline only); and a sham group. Acute hind limb ischemia-reperfusion was established by clamping the
abdominal aorta for 1 h. HBO treatment and IL infusion were administrated during 60 min of ischemia and 60 min
of reperfusion period. Blood pH, partial pressure of oxygen, partial pressure of carbon dioxide and levels of
bicarbonate, sodium, potassium, creatine kinase, lactate dehydrogenase, and tumor necrosis factor alpha were
determined at the end of the reperfusion period. Malondialdehyde was measured in the plasma and lung as an
indicator of free radicals. After sacrifice, left lungs were removed and histopathological examination determined the
degree of lung injury.
Results: In the control group, blood partial pressure of oxygen and bicarbonate levels were significantly lower and
creatine kinase, lactate dehydrogenase, malondialdehyde and tumor necrosis factor-α levels were significantly
higher than those of the HBO group, IL group, HBO+ IL group and sham group. Similarly, the malondialdehyde
levels in the lung tissue and plasma levels were significantly lower in the treatment groups compared with the
control group. The extent of lung injury according to the histological findings was significantly higher in the control
group.
Conclusions: These results suggest that both HBO and IL therapies and their combination might be effectively
used in the prevention of lung injury after ischemia/reperfusion injury of the lower extremities.
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Re-establishing perfusion after an ischemic period in a
tissue worsens the initial ischemic injury. This process
is known as ischemia/reperfusion injury (IRI) [1]. Sur-
gical interventions that need temporary aortic cross
clamping are followed by ischemia and reperfusion (I/R)
of distal extremities. IRI may occur in an ischemic
extremity or organ (local injury) or in distal parts far
from ischemic areas. Intestinal I/R may be the source
of proinflammatory mediators with the release of cyto-
kines such as TNF-α, interleukin-1β and activation
of polimorphonuclear cells, which play a major role
in this injury [2]. In fact, TNF-α was reported as an
essential cytokine in the inflammatory response after
I/R, and as a pleiotropic cytokine that might trigger
either cell death or proliferation. Free oxygen radicals
at the very beginning of reperfusion are known to
increase the harmful effect of injury [3]. Free radical-
induced peroxidation of cell membrane macromole-
cules is an important element of IRI. Lipid peroxidation
occurring during I/R is a chain reaction leading to
the oxidation of polyunsaturated fatty acids that, in turn,
disrupts the structure of biological membranes and
produces toxic metabolites, such as malondialdehyde
(MDA) [4].
Remote organ damage caused by I/R of the lower limb
targets the lungs, a fact which is of major importance.
I/R of the lower limb leads to pulmonary edema by means
of pulmonary vasoconstriction, pulmonary hypertension
and a rise in alveolar membrane permeability [2]. Vari-
ous drugs have been reported to reduce IRI during aortic
cross clamping [5,6]. Recently, studies have demon-
strated that hyperbaric oxygenation (HBO) limits the
consequences of IRI in various tissues [7,8]. It has been
proposed that HBO affects factors contributing to the
pathogenesis of IRI, including neutrophils, the endothe-
lium, inflammatory mediators, lipid peroxidation and
microvascular blood flow [8]. HBO treatment involves
the inspiration of 100% oxygen intermittently for 60 to
90 min at a pressure higher than normal atmospheric
pressure. Exposure to HBO increases the dissolved oxy-
gen concentration in the arterial blood (pO2) and
enhances the rate of diffusion of oxygen into poorly per-
fused tissues [9]. The neuroprotective effect of iloprost
(IL), a stable prostacyclin analog, has received attention
and has been used in some experimental studies. IL
mimics the pharmacodynamic properties of prostacyclin,
such as the inhibition of platelet aggregation, vasodilata-
tion and cytoprotection [10]. Pretreatment with IL de-
creases pulmonary injury after ischemia [11].
The aim of the present study was to examine the po-
tential protective effects of HBO and IL on lung damage
induced by limb I/R in a rabbit model, using both bio-
chemical and histopathological aspects.Methods
The experimental procedure was in accordance with the
Position of the American Heart Association on Research
Animal Use [12]. Animal care complied with the Princi-
ples of Laboratory Animal Care as formulated by the
National Society for Medical Research and the Guide for
the Care and Use of Laboratory Animals (National Insti-
tutes for Health publication No. 5377–3, 1996). The
experimental study was approved by the Animal Research
Ethics Committee of Rize University Medical Faculty.
All animals were given 5 days of adaptation to their envir-
onment prior to experiments. The room temperature was
kept between 28 °C to 30 °C.
Experimental protocol
Forty New Zealand white male rabbits, weighing 2.5 to
3 kg, were randomly allocated into one of five study
groups. The experiment was continued until eight ani-
mals in each group survived during the entire procedure
and during the postoperative 4 h. The HBO group
received a single session of HBO treatment the IL group
received 25 ng/kg/min infusion of IL; the HBO+ IL
group received both HBO and IL; the control group
received only 0.9% saline; and the fifth group was the
sham group. HBO treatment and IL infusion were admi-
nistrated during 60 min of ischemia and 60 min of
reperfusion in the treatment groups.
Initial anesthesia was achieved with intramuscular
ketamine (50 mg/kg) and xylazine (5 mg/kg) without
endotracheal intubation; then followed by 25 mg/kg
fractionally in order to allow the animals to have spon-
taneous respiration. All animals received a similar
volume of maintenance fluids (0.9% sodium chloride,
20 ml/h) for the whole procedure. An arterial catheter
(20-gauge) was placed in an ear artery to monitor blood
pressure (Petas KMA 800, Ankara, Turkey). Each animal
received 150 U/kg heparin intravenously for anticoagula-
tion. Animals were placed in the supine position. The
infrarenal abdominal aorta was exposed through a mid-
line laparotomy incision and a transperitoneal approach,
with the abdominal contents reflected to the right. The
aorta was exposed from the left renal artery down to the
aortic bifurcation. In all animals, except the sham con-
trols (n = 8), the aorta was cross-clamped just proximal
to the aortic bifurcation using atraumatic arterial bulldog
clamps (Vascu-statt, Scanlan International, St. Paul, MN,
USA). The clamp was removed after 60 min and restor-
ation of blood flow was verified visually. Four hours after
the intervention, all animals were humanely killed by
a lethal cardiac injection of pentobarbital (100 mg/kg),
immediately after which a median sternotomy was used
to extract lung tissues for histopathological examination
by light microscopy and biochemical investigations by
MDA assay. The left lungs were removed, fixed with
Table 1 Hemodynamic parameters determined at the end














HBO group 64 ± 10 132 ± 25 6± 2 Sinus rhythm
IL group 68 ± 12 138 ± 20 8± 3 Sinus rhythm
HBO+ IL group 66 ± 8 136 ± 18 7± 3 Sinus rhythm
Control group 74 ± 10* 154 ± 28 6± 2 Sinus rhythm
Sham group 65 ± 6 134 ± 15 7± 2 Sinus rhythm
*Significantly higher than the treatment group by analysis of variance
(P <0.05). Bpm: beats per minute; HBO: hyperbaric oxygenation; IL: iloprost.
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gittal section was obtained at the level of the hilum.
These tissues were fixed again with 10% formalin for
2 days. Three animals died during the procedure, one in
the HBO group during anesthetic induction, one in the
IL group due to surgical intervention, and one in the
sham group due to hemorrhage. They were excluded
from the study.
Hyperbaric oxygen treatment procedure
Animals received HBO therapy in an animal monoplace
chamber during 60 min of ischemia and 60 min of
reperfusion period at 2.5 atmospheric pressure. Before
pressurization, 100% medical oxygen was flushed
through the chamber for 10 min to displace ambient air.
The oxygen pressure was then increased slowly and
reached 2.5 ATA in 5 min. The chamber was ventilated
during HBO therapy to avoid carbon dioxide (CO2)
accumulation. Oxygen content was monitored continu-
ously and maintained ≥98.5% (Nellcor:Draeger, Hemel
Hempstead, Hertfordshire, UK). The concentration of
CO2 was not allowed to rise above 0.1%. An environ-
mental control system maintained the inner temperature
and relative humidity at 25 ± 1 °C and 50 ± 20%, respect-
ively. After 120 min at 2.5 ATA, the chamber was
decompressed to normal atmospheric pressure in 5 min.
Biochemical analysis
Blood pH, pO2 (mmHg), pCO2 (mmHg), bicarbonate
(HCO3; mmol/L), sodium (Na
+), potassium (K+), creat-
ine kinase (CPK; IU/L), lactate dehydrogenase (LDH;
IU/L) and TNF-α (pg/mL) values were determined 1 h
after the onset of ischemia and 1 h after the onset of
reperfusion. Blood pH, pO2, pCO2, HCO3, Na
+ and K+
values were determined using a blood gas analyzer (Ciba
Corning Blood Gas Analyzer Model 860, Ciba Corning
Diagnostics Corp., Irvine, CA, USA). Plasma CPK and
LDH levels were measured in lithium heparinized
plasma using automated enzyme reactions (automated
analysis for Hitachi System 717, Boehringer Mannheim
Diagnostica, Mannheim, Germany).
TNF-α assay and malondialdehyde assay
TNF-α assays were performed according to the method
described by Pizarro et al. using the quantitative sand-
wich enzyme immunoassay technique (Quantikine M,
R&D Systems, Minneapolis, MN, USA) [13]. Lipid per-
oxidation in the lung tissue was evaluated by measuring
the level of MDA, which is the end product of lipid per-
oxidation. MDA was measured in plasma and the lung
as an indicator of free radicals. Plasma and tissue (lung)
MDA levels were determined with spectrophotometry
using thiobarbituric acid-reactive substances [14].Histopathological assay
After standard tissue preparation, 5 μm tissue sections
were obtained. The specimens were stained with
hematoxylin-eosin and examined with light microscopy
(Eclipse E200; Nikon, Tokyo, Japan). All histopatho-
logical changes were detailed in each lung tissue, includ-
ing inflammatory cell infiltration, alveolar edema,
congestion and preservation of the alveolar septum. At
least two different sections were explored in each speci-
men. The same pathologist, who was blinded to the
study, assigned a score of 0 to 4 on the basis of conges-
tion, interstitial edema, polymorphonuclear leukocyte in-
filtration and alveolar hemorrhage as follows: 0, normal
histological appearance; 1, mild and focal changes; 2,
moderate and multifocal changes; 3, marked and multi-
focal changes; 4, marked and diffuse changes.
Statistical analyses
Data were analyzed using the Statistical Package for
Social Sciences (SPSS) software (version 10.0 for Win-
dows). All differences associated with a chance proba-
bility of 0.05 or less were considered statistically
significant. All data are presented as mean ± SD. Statis-
tical analysis was performed using analysis of variance
(ANOVA) test. One-way ANOVA test was followed by
post-hoc Dunnett's test.
Results
There was no statistically significant difference between
the groups according to the preoperative, ischemia and
reperfusion periods. Hemodynamic variables of all
groups are shown in Table 1. Table 2 shows mean values
and SDs of pH, pO2, pCO2, HCO3. Table 3 shows Na
+,
K+, CPK, LDH, plasma MDA and lung MDA levels. Pre-
and postischemic mean arterial pressure was minimally
lower in HBO and IL groups when compared with con-
trols. Blood pH, PO2, and HCO3 levels of the medicated
groups were significantly higher than the levels of the
control group. Plasma CPK, plasma MDA and lung
MDA levels were significantly lower in the HBO group,
Table 2 Blood pH, partial pressure of oxygen, partial
pressure of carbon dioxide and bicarbonate levels







HBO group 7.23 ± 0.32 96.80 ± 7.02 42.60 ± 4.50 16.42 ± 5.3
IL group 7.24 ± 0.40 95.78 ± 6.35 43.75 ± 5.30 15.44 ± 7.2
HBO+ IL group 7.22 ± 0.38 97.09 ± 7.06 42.09 ± 4.08 16.75 ± 5.5
Control group 7.14 ± 0.10* 76.10 ± 6.90* 49.84 ± 6.3** 9.12 ± 6.8*
Sham group 7.23 ± 0.22 94.05 ± 4.05 44.02 ± 4.20 17.56 ± 6.2
*Significantly lower than the treatment groups by analysis of variance
(P <0.05); **significantly higher than the treatment groups by analysis of
variance (P <0.05). HBO: hyperbaric oxygenation; HCO3: bicarbonate;
IL: iloprost: pCO2: partial pressure of carbon dioxide; pO2: partial pressure of
oxygen.
Table 4 Serum tumor necrosis factor alpha values
determined preoperatively, on the first hour of ischemia









HBO group 12 ± 2.2 362 ± 41.9 152 ± 23.48
IL group 9 ± 2.4 346 ± 47.6 147.25 ± 22.78
HBO+ IL group 14 ± 2.1 314 ± 53.1 144.88 ± 32
Control group 10 ± 2.1 654 ± 40.2* 484.38 ± 40.45
Sham group 8 ± 2.03 168 ± 11.9 46.25 ± 8.35
P 0.884 0.001 0.001
*Significantly higher than the treatment groups by analysis of variance
(P <0.05). HBO: hyperbaric oxygenation; IL: iloprost.
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the control group. Administration of HBO and/or IL
suppressed MDA increase in plasma (P <0.01) and in
the lung tissue (P <0.01). Compared with the control
group, serum TNF-α levels in the treatment groups and
the sham group were found to be significantly lower in
the reperfusion period. Furthermore, combined therapy
of HBO and IL was shown to be more effective than
either treatment given singly (Table 4).
Histopathological findings are summarized in Table 5.
Diffuse severe ischemic lung injury, characterized by
bleeding, edema and interstitial congestion, was signifi-
cantly lower in the HBO group, IL group, HBO+ IL
group and sham group (P <0.01). In addition, the histo-
pathological score was significantly lower (P <0.01)
in the HBO group, IL group, HBO+ IL group and
sham group when compared with the control group
(Figures 1,2,3 and 4). There was no significant difference
between groups according to the other parameters.Discussion
The aim of the present study was to examine the poten-
tial protective effects of HBO and IL on lung damage
induced by limb I/R. Our main finding was that both
HBO and IL attenuate lung injury. Furthermore, com-
bined therapy of HBO and IL was shown to be more
effective than either treatment given singly.Table 3 Blood sodium and potassium levels, plasma lactate d
tissue malondialdehyde levels determined at the end of the r
Groups Sodium Potassium Lactate dehydro
(IU/L)
HBO group 141.36 ± 4.3 4.3 ± 1.2 622.22 ± 146.5
IL group 140.52 ± 3.8 4.6 ± 1.1 627.44 ± 134.2
HBO+ IL group 142.40 ± 4.1 4.3 ± 1.0 626.50 ± 138.3
Control group 146.32 ± 4.4 5.2 ± 0.9 646.83 ± 167.2*
Sham group 143.60 ± 7.2 4.4 ± 1.2 625.10 ± 144.3
*Significantly higher than the treatment groups by analysis of variance (P <0.05). HAlthough it is not clear why the lungs are more sus-
ceptible to injury than other remote organs (kidney,
heart, liver and so on) after I/R of the lower limbs, we
know that humoral mediators activate polymorpho-
nuclear leukocytes, lead to aggregation at the lung capil-
laries, and adhere to the vascular endothelium, activating
secretion of lysosomal enzymes that injures the lungs
[15]. It has been shown that inflammatory cells like
macrophages and mast cells in lungs produce inflamma-
tory mediators and exaggerate reperfusion injury [16].
Lung injury after lower limb I/R causes pulmonary dys-
function characterized by interstitial edema and this
leads to sustained ventilator and inotropic assistance and
causes considerable mortality and morbidity. In ischemic
injury, the basic therapy is surgical. Various drugs (apro-
tinin, alpha tocopherol, L-arginine, tacrolimus, ascorbic
acid and others) were shown to be experimentally and
clinically effective in reducing lung injury after lower
limb ischemia reperfusion [17,18]. The reduction or pre-
vention of neutrophil activation and sequestration would
reduce the incidence of IRI lung injury. This hypothesis
has been supported by studies in which it has been
shown that the depletion of neutrophils ameliorates IRI
lung injury [19].
The beneficial effects of HBO may be attributable to
its ability to reduce neutrophil activation and sequestra-
tion in IRI. Studies in animal models have shown






21.60 ± 2.3 238.04 ± 36.11
24.19 ± 2.8 240.06 ± 32.03
22.30 ± 2.2 236.90 ± 25.02
30.12 ± 1.4* 252.07 ± 46.21*
23.63 ± 0.13 238.08 ± 35.39
BO: hyperbaric oxygenation; IL: iloprost.
Figure 2 Moderate degree of ischemic lung injury
characterized by interstitial septal thickening and bleeding
areas (+) (hematoxylin and eosin × 200). Hyperbaric oxygenation
group.
Table 5 Histopathological results determined at the end
of the reperfusion period
Groups Grade 0 Grade 1 Grade 2 Grade 3 Grade 4
HBO group (n=8) 1 3 3 1 -
IL group (n=8) 1 3 3 1 -
HBO+ IL group (n=8) 2 2 3 1 -
Control group (n =8) - 1 2 2 3*
Sham group (n =8) 3 3 2 - -
*Significantly higher than the treatment groups by Chi-square test (P <0.05).
HBO: hyperbaric oxygenation; IL: iloprost.
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of ischemic tissue and decreases edema [20,21]. HBO
has also been shown to reduce leukocyte adherence to
venular endothelium in I/R of skeletal muscle, suggest-
ing a reduction in the inflammation of the postischemic
tissue [22]. The mechanisms behind this effect are not
known, but the limited amount of available experimental
data indicate that HBO, directly or indirectly, interacts
with mediators that control the local inflammatory
response [23]. Because HBO has been shown to exert
anti-inflammatory effects in experimental skeletal muscle
ischemia, it could have anti-inflammatory effects in other
types of inflammation as well, although the most prob-
able explanation for the reduction in the local inflamma-
tion in ischemia is a reduction in local ischemic tissue
damage. In an intestinal IRI model, rats underwent
90 min of reperfusion after 2 h of ischemia. HBO was
administered during the reperfusion period and a signifi-
cant reduction in lung neutrophil sequestration was
observed [8].
The beneficial effect of HBO on lung neutrophil
sequestration may be achieved when it is administered
during either the period of ischemia or the reperfusion.
Rossman et al. reported that perfusing the lumen of the
intestine with oxygenated perfluorocarbon during a period
of ischemia reduced mucosal injury and associated lungFigure 1 Healthy lung tissue without ischemic injury
(hematoxylin and eosin × 200). Hyperbaric oxygenation+ iloprost
group.injury [24]. Ueno et al. showed that early posthepatectomy
HBO treatment decreased neutrophil activation and
improved the outcome [25]. Convincingly, HBO should
be administered as early as possible during I/R to obtain a
favorable effect. In our study, both HBO and IL therapies
were administered from the beginning of ischemia and
continued during the reperfusion period.
There is disagreement concerning HBO therapy in IRI,
due to the hypothesis that HBO can cause an increase in
reactive oxygen derivatives, which can lead to tissue
damage by lipid peroxidation when present in excess
[26]. However, Chen et al. reported that HBO reduces
lipid peroxidation in hepatic ischemia reperfusion [27].
Similarly in another study it was pointed out that HBO
therapy at an appropriate pressure and within the appro-
priate time period reduces free oxygen radicals in ani-
mals [28]. It was noted that HBO therapy is safe using
a standard protocol, with a pressure of not more thanFigure 3 Moderate degree of ischemic lung injury
characterized by interstitial septal thickening and bleeding
areas (+++) (hematoxylin and eosin × 200). Iloprost group.
Figure 4 Diffuse, severe ischemic lung injury characterized by
bleeding, edema and interstitial congestion (hematoxylin
and eosin × 200). Control group.
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tective effect of HBO in this study shows that it suppresses
the specific enzymes that catalyze lipid peroxidation.
Iloprost, a stable prostacyclin analog, acts as a mem-
brane stabilizer and inhibits the function of neutrophils,
which are potential mediators of I/R injury. Iloprost also
decreases white blood cell aggregation and adhesion to
the vascular endothelium, superoxide radical production
from stimulated canine and human neutrophils, and free
radical formation in myocardium subjected to ISI [29].
Iloprost had demonstrated its protective effects when
infused during the clamping period in previous studies
[30,31]. We obtained the dosage of the agent from a
study performed by Katircioglu et al. [30]. In that study,
administration was started at a lower rate before the aor-
tic occlusion, and increased to the definitive dose of
25 ng/kg/min. Instead of doing this, we started directly
at the definitive level to obtain the maximal physiologic
effect before aortic occlusion. We did not perform a sep-
arate dose–response effect experiment. IL infusion was
administrated during 60 min of ischemia and 60 min of
reperfusion in the treatment groups.
In the present study, plasma MDA levels, serum LDH
levels and arterial blood gas were measured to evaluate
the I/R damage. Clinical research in the area of lipid per-
oxidation has been hampered by the lack of a valid bio-
marker. One of the most frequently used biomarkers
providing an indication of the overall lipid peroxidation
level is MDA [32]. MDA, a more stable and longer-living
product of lipid peroxides, is often assayed as reflecting
lipid peroxidation level. MDA is a marker that increases
during reperfusion as an indicator of free radicals. Plasma
and lung MDA levels in the control group were found to
be significantly higher in the reperfusion period.
The involvement of neutrophils in I/R lung injury is
important [8]. Neutrophils are activated during ischemia,and their adhesiveness and rigidity increase. During
reperfusion, activated neutrophils are trapped within the
lung and adhere to endothelial cells, generating oxidants
and proteases [33]. Many mediators induce neutrophil
activation, including TNF-α. The involvement of TNF-α
in IRI is evidenced by two facts, that the production of
TNF-α increases in IRI [34,35] and that the blockade of
TNF-α activity reduces I/R-induced lung injury [35].
Yang et al. hypothesized that the suppressing effect
of HBO on TNF-α production contributes to a reduced
I/R-induced acute lung injury [36]. Our results support
their hypothesis. Compared with the control group,
serum TNF-α levels in the treatment groups and the
sham group were found to be significantly lower in the
reperfusion period. The histological lung injury score of
the combined therapy group (HBO+ IL) was not statisti-
cally different from the single therapy groups. However,
the score in the HBO+ IL group was (although statisti-
cally not significant) better than both the HBO group
and IL group.
When the hemodynamic data were evaluated, no sig-
nificant changes were seen in the vital signs of the ani-
mals. In the present study, the arterial blood gas samples
were collected in the reperfusion period. Products of
anaerobic metabolism enter the systemic circulation
following the unclamping of the aorta. The level of CO2
released from ischemic tissue may increase during the
clamping [37]. Because the blood circulation and oxygen
delivery to the tissues decrease, the cellular metabolism
supplies the required energy from the high-energy phos-
phates and lactic anaerobic method. This in turn causes
increases in the lactate levels. Lactate levels can increase
rapidly in the blood together with the release of the clamp
[32]. The serum LDH level in the control group was
found to be significantly higher in the reperfusion period.
Conclusion
The present study showed that both HBO and IL reduce
lipid peroxidation. Furthermore, combined therapy of
HBO and IL was shown to be more effective than either
treatment given alone. We also hypothesize that the
combined effect may be related to the IL minimizing
the side effects of HBO with its antioxidant property,
and strengthening the effect of HBO by lowering
lipid peroxidation.
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